rss
Br J Ophthalmol 86:517-520 doi:10.1136/bjo.86.5.517
  • Scientific correspondence

S antigen specific effector T cell activation detected by cytokine flow cytometry

Table 1

Autoimmune uveitis patient details and responses to SAg

Patient No Clinical diagnosis Activity Duration of current episode Total disease duration Systemic therapy Response to SAg
1 Intermediate uveitis Inactive NA 1 year None Negative
2 Panuveitis Moderate >3 months 6 years Tacrolimus 7 mg/day Positive
Prednisolone 10 mg/day
3 Posterior uveitis Mild >3 months 11 months None Negative
4 Posterior uveitis Severe <3 months 1 month None Positive
5 Intermediate uveitis Mild >3 months 11 years None Negative
6 Intermediate uveitis Mild <3 months 13 months None Positive
7 Posterior uveitis Moderate >3 months 17 years None Negative
8 Intermediate uveitis Mild >3 months 8 months None Negative
9 Intermediate uveitis Mild >3 months 2 years, 10 months None Negative
10 Panuveitis Moderate <3 months 18 years None Positive
11 Posterior uveitis Mild >3 months 5 years Cyclosporin 150 mg/day Equivocal
Prednisolone 5 mg/day
12 Intermediate uveitis Mild >3 months 2 years None Negative
13 Intermediate uveitis Inactive NA 3 years, 3 months None Negative

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.